Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Health Care Factors Related to Stage at Diagnosis and Survival Among Medicare Patients With Colorectal Cancer

Datos Bibliográficos

ID9103816
AutoresAnna Lee-Feldstein, Anna Lee‐Feldstein (autor de correspondencia), Paul J Feldstein (University of California, Irvine), Thomas C Buchmueller (0000-0002-3068-7419, University of California, Irvine), Thomas Buchmueller
Año2002
Volumen40
Número5
Páginas362-374
Fecha de publicación2002-05-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaMedical Care (JOURNAL)
Identificadores de la revistaISSN: 0025-7079 • E-ISSN: 1537-1948
EditorialOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/00005650-200205000-00002
PMID11961471
OpenAlexW2325838624
IdiomaEN
Citas recibidas6
Referencias citadas37

BACKGROUND: With the growth in enrollment of Medicare patients in HMOs the effectiveness of care received by Medicare/HMO patients continues to be of concern. By considering the relationship of insurance to stage at diagnosis, this study inquires whether HMOs emphasize early diagnosis of colorectal cancer to a greater extent than FFS plans, if particular HMO types (group/nongroup models) are more successful in doing so, and how this pertains to survival. METHODS: Data for 1329 Medicare patients with colorectal cancer, diagnosed 1987 to 1993, and residing in northern California, were acquired from a population-based cancer registry. Insurance included two types of Medicare HMOs (group and nongroup model) and three fee-for-service (FFS) categories: Medicare with private supplement, Medicare/Medicaid, and Medicare only. The relationships of insurance to AJCC stage at diagnosis and of insurance to survival following diagnosis were examined, respectively, with logistic regression models and survival analysis (controlling for age, ethnicity, tumor location, educational level, sex, and hospital type). RESULTS: Likelihood of early stage colorectal cancer was greater for Medicare patients in nongroup model HMOs or having private FFS supplements than for those in group model HMOs, Medicare/Medicaid, or Medicare alone. All-cause and colorectal cancer mortality did not differ significantly among Medicare patients with group model HMO, nongroup model HMO and private FFS supplements. Medicare/Medicaid patients experienced significantly greater all-cause mortality than private FFS patients. CONCLUSIONS: Differences within this study population in early stage diagnosis of colorectal cancer and breast cancer, respectively, by type of Medicare supplemental insurance may be attributable to which preventive screening measures are included in health plan report cards

Cancer · Cancer registry · Colorectal cancer · Environmental health · Fee-for-service · Health care · Logistic regression · Medicaid · Population · Stage (stratigraphy) · Demography · Global Cancer Incidence and Screening · Healthcare Policy and Management · Internal Medicine · Medicine · Oncology · Primary Care and Health Outcomes

  • Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes

    Open Access•Rebecca Myerson, Rebecca M Myerson et al.•Journal of Policy Analysis and…•2020

  • Cancer of the Colorectum in Maine, 1995‐1998

    Open Access•Margaret A Parsons, Kathleen D Askland•The Journal of Rural Health•2007

  • Factors Associated With Colorectal Cancer Screening Among the US Urban Japanese Population

    Keiko Honda•American Journal of Public Health•2004

  • Costs and Survival of Patients With Colorectal Cancer in a Health Maintenance Organization and a Preferred Provider Organization

    Matthew Kerrigan, Nadia Howlader et al.•Medical Care•2005

  • Comparison of Cancer Diagnosis and Treatment in Medicare Fee-for-Service and Managed Care Plans

    Gerald F Riley, Joan L Warren et al.•Medical Care•2008

  • Do HMO Market Level Factors Lead to Racial/Ethnic Disparities in Colorectal Cancer Screening

    Ninez A Ponce, Soonim Huh et al.•Medical Care•2005

  • Measuring Social Class in US Public Health Research

    Nancy Krieger, David R Williams et al.•Annual Review of Public Health•1997

  • Has the use of cervical, breast, and colorectal cancer screening increased in the United States

    Laura M Anderson, Daniel May et al.•American Journal of Public Health•1995

  • Colorectal Cancer Screening Participation

    Stephenie C Lemon, Stephenie Lemon et al.•American Journal of Public Health•2001

  • Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees

    Gerald F Riley, Arnold L Potosky et al.•American Journal of Public Health•1994

  • The Relationship of HMOs, Health Insurance, and Delivery Systems to Breast Cancer Outcomes

    Anna Lee-Feldstein, Anna Lee‐Feldstein et al.•Medical Care•2000

  • Preventive Services Among Medicare Beneficiaries With Supplemental Coverage Versus HMO Enrollees, Medicaid Recipients, and Elders With No Additional Coverage

    Olveen Carrasquillo, Rafael Lantigua et al.•Medical Care•2001

  • The Association Between Health Care Coverage and the Use of Cancer Screening Tests

    Arnold L Potosky, Nancy Breen et al.•Medical Care•1998

Obras citantes distintas6
Citas por año0,27
Intervalo de citas2004 - 2020 (17)
Velocidad de citaciónhistorical
Altamente citadoNo
Tipos de citaNeutras: 6
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae